Pain is one of the most common symptoms in children suffering from leukemia, who are often misdiagnosed with other childhood painful diseases such as juvenile idiopathic arthritis. Corticosteroid-induced osteonecrosis (ON) and vincristine-induced peripheral neuropathy (VIPN) are the most common painful manifestations. Additionally, ongoing pain may continue to impact quality of life in survivorship. This narrative review focuses on the pathophysiological mechanisms of pain in childhood leukemia and current available indications for analgesic treatments. Pain management in children is often inadequate because of difficulties in pain assessment, different indications across countries, and the lack of specific pediatric trials. Analgesic drugs are often prescribed off-label to children by extrapolating information from adult guidelines, with possible increased risk of adverse events. Optimal pain management should involve a multidisciplinary team to ensure assessment and interventions tailored to the individual patient.

Pain management in childhood leukemia. Diagnosis and available analgesic treatments / Coluzzi, Flaminia; Rocco, Monica; Green Gladden, Rula; Persiani, Pietro; Thur, Laurel A; Milano, Filippo. - In: CANCERS. - ISSN 2072-6694. - 12:12(2020), pp. 1-13. [10.3390/cancers12123671]

Pain management in childhood leukemia. Diagnosis and available analgesic treatments

Coluzzi, Flaminia
;
Rocco, Monica;Persiani, Pietro;
2020

Abstract

Pain is one of the most common symptoms in children suffering from leukemia, who are often misdiagnosed with other childhood painful diseases such as juvenile idiopathic arthritis. Corticosteroid-induced osteonecrosis (ON) and vincristine-induced peripheral neuropathy (VIPN) are the most common painful manifestations. Additionally, ongoing pain may continue to impact quality of life in survivorship. This narrative review focuses on the pathophysiological mechanisms of pain in childhood leukemia and current available indications for analgesic treatments. Pain management in children is often inadequate because of difficulties in pain assessment, different indications across countries, and the lack of specific pediatric trials. Analgesic drugs are often prescribed off-label to children by extrapolating information from adult guidelines, with possible increased risk of adverse events. Optimal pain management should involve a multidisciplinary team to ensure assessment and interventions tailored to the individual patient.
2020
children; chronic pain; leukemia; musculoskeletal pain; neuropathic pain; opioids; osteonecrosis
01 Pubblicazione su rivista::01g Articolo di rassegna (Review)
Pain management in childhood leukemia. Diagnosis and available analgesic treatments / Coluzzi, Flaminia; Rocco, Monica; Green Gladden, Rula; Persiani, Pietro; Thur, Laurel A; Milano, Filippo. - In: CANCERS. - ISSN 2072-6694. - 12:12(2020), pp. 1-13. [10.3390/cancers12123671]
File allegati a questo prodotto
File Dimensione Formato  
Coluzzi_Pain-management_2020.pdf

accesso aperto

Note: https://www.mdpi.com/2072-6694/12/12/3671
Tipologia: Versione editoriale (versione pubblicata con il layout dell'editore)
Licenza: Creative commons
Dimensione 251.62 kB
Formato Adobe PDF
251.62 kB Adobe PDF

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11573/1471249
Citazioni
  • ???jsp.display-item.citation.pmc??? 1
  • Scopus 10
  • ???jsp.display-item.citation.isi??? 8
social impact